◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
美康生物 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
+Revenue 1.7B 1.9B 2.5B 2.3B 2.3B
Revenue Growth % -7.6% -24.2% 10.5% -2.2% --
Total Revenue 1.7B 1.9B 2.5B 2.3B 2.3B
Cost Of Revenue 966.0M 1.1B 1.5B 1.3B 1.5B
+Gross Profit 776.0M 832.0M 950.0M 912.0M 848.0M
Gross Margin % 44.5% 44.1% 38.2% 40.5% 36.8%
Total Operating Cost 1.5B 1.7B 2.3B 2.1B 2.2B
Selling Expenses 237.0M 254.0M 300.0M 298.0M 273.0M
Admin Expenses 166.0M 187.0M 175.0M 177.0M 189.0M
Rd Expenses 146.0M 150.0M 172.0M 151.0M 135.0M
Finance Expenses -5.1M -1.7M 4.8M 26.1M 53.5M
+Operating Income 268.0M 279.0M 229.0M 220.0M 173.0M
Operating Margin % 15.4% 14.8% 9.2% 9.8% 7.5%
Non Operating Income 21.9M 19.2M 97,300 1.1M 179.0M
Non Operating Expenses 7.1M 2.7M 5.4M 2.6M 4.7M
Investment Income 14.5M 14.9M 3.7M -3.4M 17.1M
Fair Value Change Income 81,500 -- 165,300 697,600 --
Asset Disposal Income -665,900 -782,400 -321,700 479,100 3.2M
Asset Impairment Loss 17.8M 21.3M 34.7M 24.5M 63.6M
Other Income 34.2M 30.3M 25.5M 30.8M 30.8M
Income Before Tax 282.0M 296.0M 223.0M 218.0M 347.0M
Income Tax 19.7M 36.2M 18.1M 28.1M 53.5M
+Net Income 263.0M 260.0M 205.0M 190.0M 294.0M
Net Margin % 15.1% 13.8% 8.2% 8.4% 12.8%
Net Income Attributable 258.0M 257.0M 199.0M 179.0M 299.0M
Minority Interest 4.7M 2.9M 6.7M 10.7M -5.9M
Eps Basic 0.67 0.67 0.52 0.48 0.87
Eps Diluted 0.67 0.67 0.52 0.48 0.87
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash And Equivalents 729.0M 959.0M 806.0M 666.0M 328.0M
Trading Financial Assets 161.0M 6.0M 80.2M 101.0M --
Accounts Receivable 553.0M 568.0M 816.0M 811.0M 856.0M
Notes Receivable 237,100 -- 380,000 -- 1.5M
Notes And Accounts Receivable 553.0M 568.0M 816.0M 811.0M 858.0M
Prepayments 30.1M 44.4M 64.6M 45.3M 40.1M
Inventory 286.0M 259.0M 218.0M 211.0M 254.0M
Total Current Assets 1.8B 1.9B 2.1B 2.0B 1.6B
Long Term Equity Investment 186.0M 156.0M 157.0M 179.0M 251.0M
Fixed Assets -- 982.0M 831.0M 860.0M 931.0M
Fixed Assets Total 1.4B 982.0M 831.0M 860.0M 931.0M
Construction In Progress -- 161.0M 190.0M 141.0M 115.0M
Construction In Progress Total 12.0M 161.0M 190.0M 141.0M 115.0M
Intangible Assets 135.0M 128.0M 120.0M 148.0M 163.0M
Long Term Deferred Expenses 39.8M 34.3M 18.6M 35.2M 65.9M
Total Non Current Assets 1.9B 1.6B 1.5B 1.6B 1.7B
Total Assets 3.7B 3.5B 3.6B 3.6B 3.3B
Short Term Borrowings 30.0M 50.1M 218.0M 340.0M 782.0M
Accounts Payable 362.0M 318.0M 354.0M 331.0M 277.0M
Advance Receipts -- -- 1.5M 5.9M 5.0M
Contract Liabilities 63.8M 88.3M 75.5M 37.9M 56.5M
Total Current Liabilities 667.0M 699.0M 981.0M 1.1B 1.4B
Long Term Borrowings -- -- 7.0M 45.0M 97.0M
Total Non Current Liabilities 104.0M 83.4M 82.9M 141.0M 178.0M
Total Liabilities 772.0M 782.0M 1.1B 1.2B 1.6B
Paid In Capital 384.0M 383.0M 383.0M 383.0M 343.0M
Capital Reserve 1.1B 1.1B 1.1B 1.1B 570.0M
Surplus Reserve 135.0M 121.0M 121.0M 121.0M 121.0M
Retained Earnings 1.3B 1.1B 914.0M 752.0M 632.0M
Minority Equity -6.4M -8.2M 9.4M 43.7M 45.3M
Equity Attributable 2.9B 2.7B 2.5B 2.3B 1.6B
Total Equity 2.9B 2.7B 2.5B 2.4B 1.7B
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash From Sales 1.9B 2.3B 2.7B 2.3B 2.8B
Tax Refunds Received 8.3M -- 6.6M 12.2M 4.7M
Total Operating Cash Inflow 2.0B 2.4B 2.7B 2.4B 3.0B
Cash Paid For Goods 867.0M 962.0M 1.3B 1.1B 1.2B
Cash Paid To Employees 386.0M 398.0M 433.0M 387.0M 347.0M
Taxes Paid 107.0M 132.0M 136.0M 140.0M 112.0M
Total Operating Cash Outflow 1.6B 1.8B 2.2B 1.9B 2.1B
Operating Cash Flow 398.0M 634.0M 565.0M 515.0M 912.0M
Total Investing Cash Inflow 1.0B 408.0M 351.0M 315.0M 150.0M
Total Investing Cash Outflow 1.5B 570.0M 584.0M 502.0M 403.0M
Investing Cash Flow -527.0M -162.0M -232.0M -188.0M -253.0M
Cash From Borrowings 30.0M 50.0M 213.0M 387.0M 1.0B
Dividends And Interest Paid 52.5M 54.9M 50.7M 91.4M 125.0M
Debt Repayments 57.0M 278.0M 362.0M 864.0M 1.6B
Total Financing Cash Inflow 32.1M 57.2M 213.0M 1.0B 1.0B
Total Financing Cash Outflow 129.0M 361.0M 434.0M 976.0M 1.8B
Financing Cash Flow -96.4M -304.0M -221.0M 24.2M -774.0M
Net Change In Cash -226.0M 168.0M 110.0M 353.0M -115.0M
Ending Cash Balance 727.0M 952.0M 784.0M 674.0M 321.0M
Capex 421.0M 280.0M 303.0M 202.0M 383.0M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...